メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
岡山大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
設備
活動
プレス/メディア
受賞
専門知識、名前、または所属機関で検索
大学院医歯薬学総合研究科
岡山大学
大学院
概要
フィンガープリント
ネットワーク
プロファイル
(285)
研究成果
(13228)
受賞
(2)
フィンガープリント
大学院医歯薬学総合研究科が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Neoplasm
100%
Disease
47%
Malignant Neoplasm
47%
Surgery
44%
Computer Assisted Tomography
43%
Recurrent Disease
34%
Non Small Cell Lung Cancer
33%
Lung Cancer
33%
Magnetic Resonance Imaging
31%
Overall Survival
28%
Cancer Cell
26%
Adverse Event
25%
Lung Transplantation
24%
Diagnosis
22%
Retrospective Study
22%
Bleeding
22%
Symptom
21%
Odds Ratio
20%
Hepatocellular Carcinoma
20%
Survival Rate
20%
In Vitro
20%
Metastatic Carcinoma
19%
Observational Study
19%
Infection
18%
Stomach Cancer
18%
Radiofrequency Ablation
18%
Radiation Therapy
17%
Optical Coherence Tomography
17%
Epidermal Growth Factor Receptor
16%
Biopsy
16%
Injury
16%
Arm
15%
Endoscopic Submucosal Dissection
15%
Prognostic Factor
14%
Chemoradiotherapy
14%
Knee
14%
Multivariate Analysis
13%
Prevalence
13%
Squamous Cell Carcinoma
13%
Cohort Analysis
13%
Lymph Node Metastasis
13%
Hazard Ratio
12%
Cross Sectional Study
12%
Clinical Trial
12%
Soft Tissue Sarcoma
12%
Biological Marker
12%
Mouth Squamous Cell Carcinoma
11%
Telomerase
11%
Pediatrics
11%
Esophageal Cancer
11%
Brugada Syndrome
11%
Programmed Cell Death
11%
Dentin
11%
Pancreas Cancer
10%
Breast Cancer
10%
Cancer
10%
Immunohistochemistry
10%
Chronic Kidney Disease
10%
Elderly Patient
10%
Periodontitis
10%
Tumor Cell
10%
Quality of Life
10%
Pulmonary Hypertension
10%
Cisplatin
10%
Fibroblast
10%
Gene Expression
10%
Heart Failure
10%
Edentulism
10%
Lower Jaw
9%
Suture Material
9%
Diabetes Mellitus
9%
Osteosarcoma
9%
Combination Therapy
9%
Progression Free Survival
9%
Adenoviridae
9%
Apoplexy
9%
Prospective Cohort Study
9%
Salicylic Acid
9%
Epileptic Absence
9%
Lymph Node
9%
Randomized Controlled Trial
9%
Logistic Regression Analysis
8%
Rheumatoid Arthritis
8%
MALT Lymphoma
8%
Immunoglobulin G4
8%
COVID-19
8%
Lung Metastasis
8%
Atrial Septal Defect
8%
Body Mass Index
8%
Endoscopic Ultrasound
8%
Chondrocyte
8%
Postoperative Complication
8%
Bone Tissue
8%
Cancer Surgery
8%
Surgical Technique
8%
Retrospective Cohort Study
8%
Resuscitation
8%
Tumor Progression
8%
Carcinoma
7%
Liver Transplantation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
72%
Neoplasm
66%
Malignant Neoplasm
58%
Disease
42%
Non Small Cell Lung Cancer
37%
Lung Cancer
31%
Chemotherapy
29%
Epidermal Growth Factor Receptor
26%
Liver Cell Carcinoma
23%
Inflammation
22%
Overall Survival
19%
Mouse Model
19%
Adverse Event
19%
Symptom
17%
Infection
16%
Recurrent Disease
15%
Protein P53
15%
Cytokine
15%
Receptor
14%
Combination Therapy
14%
Prevalence
13%
Clinical Trial
13%
Antioxidant
13%
Biological Marker
13%
Cisplatin
12%
Survival Rate
12%
Tumor Necrosis Factor
12%
Adenoviridae
12%
Stomach Cancer
11%
Chemoradiation Therapy
11%
Observational Study
11%
Cohort Study
11%
Periodontitis
11%
Doxorubicin
10%
Breast Cancer
10%
Retinoid X Receptor
10%
Histamine
10%
Telomerase
10%
Progression Free Survival
10%
Nonalcoholic Fatty Liver
10%
Chronic Kidney Failure
9%
Hepatitis C Virus
9%
Normal Human
9%
Alzheimer's Disease
9%
Pancreas Cancer
9%
Tumor Growth
9%
Parkinson's Disease
9%
Pulmonary Hypertension
9%
Diabetes Mellitus
8%
Interferon
8%
Retrospective Study
8%
Injury
8%
Esophagus Cancer
8%
Lipopolysaccharide
8%
Therapeutic Effect
8%
Cardiovascular Disease
8%
Neuroprotective Agent
8%
Heart Failure
8%
Remission
7%
Pharmacokinetics
7%
Dopamine Receptor Stimulating Agent
7%
Reactive Oxygen Metabolite
7%
Randomized Controlled Trial
7%
Calcium Ion
7%
Interleukin 18
7%
Syndrome
7%
Histidine
7%
Glycoprotein
7%
Asthma
7%
Ischemia
7%
Oncolytic Adenovirus
7%
Brugada Syndrome
7%
Proteinase
7%
Paclitaxel
7%
Receptor Agonist
7%
Cross-Sectional Study
7%
Interleukin 6
7%
Intercellular Adhesion Molecule 1
7%
Acute Kidney Failure
6%
Tumor Suppressor Protein
6%
Coronary Artery Disease
6%
Rheumatoid Arthritis
6%
Vasculotropin
6%
Monoclonal Antibody
6%
Immune Checkpoint Inhibitor
6%
Phosphotransferase
6%
microRNA
6%
Metastasis
6%
Virotherapy
6%
Squamous Cell Carcinoma
6%
Bleeding
6%
Fibrosis
6%
Edaravone
6%
Epidermal Growth Factor Receptor Kinase Inhibitor
6%
Adenovirus Vector
6%
Fluorine 18
6%
Gamma Urogastrone
6%
Gefitinib
6%
Carcinogenesis
6%
Atherosclerosis
6%
Keyphrases
Japan
28%
Non-small Cell Lung Cancer (NSCLC)
15%
Tumor
14%
Confidence Interval
13%
Okayama
9%
Oxidative Stress
9%
Lung Cancer
8%
Histamine
8%
Lung Transplantation
8%
Clinical Outcomes
7%
Overall Survival
7%
Risk Factors
7%
Telomerase
7%
Medial Meniscus Posterior Root Tear
7%
Adenovirus
7%
Cisplatin
6%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
6%
Cancer Cells
6%
Odds Ratio
6%
Japanese Patients
6%
Apoptosis
6%
EGFR mutation
6%
Hazard Ratio
6%
Radiofrequency Ablation
6%
High Mobility Group Box 1 (HMGB1)
5%
Gastric Cancer
5%
CCN2
5%
Antitumor Effect
5%
Gene Expression
5%
Computed Tomography
5%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
5%
Tumor Necrosis Factor-α
5%